Safety and Efficacy of Azacitidine and Chidamide Maintenance after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with High-Risk Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase II Clinical Trial

被引:0
|
作者
Yang, Chuting [1 ]
Zheng, Yaling [1 ]
Song, Chaoyang [2 ]
Wu, Ming [1 ]
Wang, Lei [1 ]
Zhou, Xuan [1 ]
Yue, Chunyan [1 ]
Lin, Xiaonan [1 ]
Chen, Jie [3 ]
Zeng, Hui [3 ]
Huang, Rui [1 ]
Li, Yuhua [2 ]
机构
[1] Southern Med Univ, Dept Hematol, Zhujiang Hosp, Guangzhou, Peoples R China
[2] Southern Med Univ, Zhujiang Hosp, Dept Hematol, Guangzhou, Peoples R China
[3] Jinan Univ, Dept Hematol, Affiliated Hosp 1, Guangzhou, Peoples R China
关键词
D O I
10.1182/blood-2023-174879
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Which Patients Will Benefit More?-the Impact of Different Biological Characteristics of High-Risk Acute Myeloid Leukemia on the Efficacy of Maintenance Treatment with Decitabine after Allogeneic Hematopoietic Stem Cell Transplantation
    Liu, Jia
    Zhu, Lidan
    Liu, Huanfeng
    Gao, Shichun
    Wang, Lu
    Kong, Peiyan
    Zhang, Xi
    Gao, Lei
    BLOOD, 2024, 144 : 7435 - 7435
  • [32] Low-Dose Azacitidine Maintenance Therapy Post-Allogeneic Stem Cell Transplantation for High-Risk Pediatric Acute Myeloid Leukemia
    Tamura, A.
    Ishida, T.
    Saito, A.
    Yamamoto, N.
    Yokoi, T.
    Uemura, S.
    Nino, N.
    Nakamura, S.
    Kozaki, A.
    Kishimoto, K.
    Hasegawa, D.
    Kosaka, Y.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S191 - S191
  • [34] A Phase II Study of Decitabine Followed By Allogeneic Hematopoietic Stem Cell Transplantation in High-Risk Patients with Myeloid Malignancies
    D'Angelo, Christopher R.
    Hall, Aric C.
    Kim, Kyungmann
    Mattison, Ryan J.
    Longo, Walter L.
    Hematti, Peiman
    Callander, Natalie Scott
    Juckett, Mark
    BLOOD, 2018, 132
  • [35] Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Children and Adolescents with Acute Myeloid Leukemia and High-Risk Cytogenetics
    Tomizawa, D.
    Yoshida, M.
    Kondo, T.
    Miyamura, T.
    Taga, T.
    Adachi, S.
    Koh, K.
    Noguchi, M.
    Kakuda, H.
    Shiba, N.
    Watanabe, K.
    Inoue, M.
    Hashii, Y.
    Atsuta, Y.
    Ishida, H.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S85 - S86
  • [36] Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Children and Adolescents with Acute Myeloid Leukemia and High-Risk Cytogenetics
    Tomizawa, D.
    Yoshida, M.
    Kondo, T.
    Miyamura, T.
    Taga, T.
    Adachi, S.
    Koh, K.
    Noguchi, M.
    Kakuda, H.
    Shiba, N.
    Watanabe, K.
    Inoue, M.
    Hashii, Y.
    Atsuta, Y.
    Ishida, H.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S192 - S193
  • [37] Venetoclax Plus Azacitadine for Middle Aged and Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase 2 Trial
    Huang, Rui
    Lin, Xiaonan
    Zhang, Yuming
    Su, YongZhong
    Wang, Caixia
    Zhou, Jihao
    Huang, Zhenqian
    Huang, Jinxiong
    Zhang, Xiong
    Zhao, Ying
    Liang, Yuexiong
    Wang, Xiaotao
    Gu, Xuekui
    He, Honghua
    Zheng, Yaling
    Tu, Sanfang
    Chen, FeiHeng
    Lin, Shaoze
    Wang, Yaya
    Dong, Ying
    Huang, Pengcheng
    Liu, Zenghui
    Xu, Xiaoli
    Liang, Zhao
    Zhou, Xuan
    Li, Meifang
    Luo, Man
    Wu, Ming
    Jiang, Fang
    Liu, Qin
    Zeng, Hui
    Song, Chaoyang
    Li, Yuhua
    BLOOD, 2023, 142
  • [38] TP53 Mutations In Patients With High-Risk Acute Myeloid Leukemia Treated With Allogeneic Hematopoietic Stem Cell Transplantation
    Middeke, Jan Moritz
    Herold, Silvia
    Ruecker-Braun, Elke
    Mohr, Brigitte
    Berdel, Wolfgang E.
    Kaufmann, Martin
    Schaefer-Eckart, Kerstin
    Baldus, Claudia D.
    Stuhlmann, Reingard
    Heidenreich, Falk
    Stoelzel, Friedrich
    Roellig, Christoph
    Platzbecker, Uwe
    Ehninger, Gerhard
    Bornhaeuser, Martin
    Thiede, Christian
    Schetelig, Johannes
    BLOOD, 2013, 122 (21)
  • [39] Safety and Efficacy of Iron Chelation with Deferasirox in Adult Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
    Jeon, Young-Woo
    Cho, Byung-Sik
    Kim, Hee-Je
    Yoon, Jae-Ho
    Shin, Seung-Hwan
    Lee, Sung-Eun
    Eom, Ki-Seong
    Kim, Yoojin
    Lee, Seok
    Min, Chang-Ki
    Cho, Seok-Goo
    Kim, Dong-Wook
    Lee, Jong-Wook
    Min, Woo-Sung
    BLOOD, 2015, 126 (23)
  • [40] Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial
    Stelljes, Matthias
    Beelen, Dietrich W.
    Braess, Jan
    Sauerland, Maria C.
    Heinecke, Achim
    Berning, Bjoerna
    Kolb, Hans J.
    Holler, Ernst
    Schwerdtfeger, Rainer
    Arnold, Renate
    Spiekermann, Karsten
    Mueller-Tidow, Carsten
    Serve, Hubert L.
    Silling, Gerda
    Hiddemann, Wolfgang
    Berdel, Wolfgang E.
    Buechner, Thomas
    Kienast, Joachim
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (07): : 972 - 979